Circulating endotoxin during initial antibiotic treatment of severe Gram-negative bacteremic infections

被引:19
作者
Maury, E
Barakett, V
Blanchard, H
Guitton, C
Fitting, C
Vassal, T
Chauvin, P
Guidet, B
Offenstadt, G
机构
[1] Hop St Antoine, INSERM, U444, Serv Bacteriol, F-75571 Paris, France
[2] Hop St Antoine, Serv Reanimat Med, F-75571 Paris, France
[3] Hop Cochin, Serv Bacteriol, Assistance Publ Hop Paris, F-75674 Paris, France
[4] Inst Pasteur, Unite Immunoallergie, F-75724 Paris, France
关键词
D O I
10.1086/517451
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The impact of antibiotics on total endotoxemia and circulating tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-8 in 18 patients with severe bacteremic sepsis or septic shock due to gram-negative species was investigated. Endotoxemia, TNF-alpha, IL-6, and IL-8 were assayed before (H0) and 1 h (H1) and 4 h (H4) after the first antibiotic infusion. Endotoxemia decreased from H0 (median, 0.4 EU/mL; interquartile interval, 0.09-1.23) to H1 (median, 0.19 EU/mL; interquartile interval, 0.07-0.75; P = .03) and remained stable between H1 and H4 (median, 0.12 EU/mL; interquartile interval, 0.09-0.30; P = .4), IL-6 levels fell between H0 and H4 (P = .01) and between H1 and H4 (P = .03). IL-8 was higher at H0 than at H1 (P = .04) and at H4 (P = .01). These results suggest that endotoxemia is not increased by antibiotherapy of severe gram-negative bacteremia.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 15 条
[1]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[2]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[3]   PLASMA ENDOTOXIN AS A PREDICTOR OF MULTIPLE ORGAN FAILURE AND DEATH IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
KIERULF, P ;
GAUSTAD, P ;
SKULBERG, A ;
BRUUN, JN ;
HALVORSEN, S ;
SORENSEN, E .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :195-204
[4]   PATTERNS OF CYTOKINES, PLASMA ENDOTOXIN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND ACUTE-PHASE PROTEINS DURING THE TREATMENT OF SEVERE SEPSIS IN HUMANS [J].
DOFFERHOFF, ASM ;
BOM, VJJ ;
DEVRIESHOSPERS, HG ;
VANINGEN, J ;
VANDERMEER, J ;
HAZENBERG, BPC ;
MULDER, POM ;
WEITS, J .
CRITICAL CARE MEDICINE, 1992, 20 (02) :185-192
[5]  
DOFFERHOFF ASM, 1995, J ENDOTOXIN RES, V2, P37
[6]   ENDOTOXEMIA AND BACTEREMIA IN PATIENTS WITH SEPSIS SYNDROME IN THE INTENSIVE-CARE UNIT [J].
GUIDET, B ;
BARAKETT, V ;
VASSAL, T ;
PETIT, JC ;
OFFENSTADT, G .
CHEST, 1994, 106 (04) :1194-1201
[7]  
HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147
[8]   BETA-LACTAM ANTIBIOTIC-INDUCED RELEASE OF FREE ENDOTOXIN - INVITRO COMPARISON OF PENICILLIN-BINDING PROTEIN (PBP) 2-SPECIFIC IMIPENEM AND PBP 3-SPECIFIC CEFTAZIDIME [J].
JACKSON, JJ ;
KROPP, H .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1033-1041
[9]   A NEW SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS-II) BASED ON A EUROPEAN NORTH-AMERICAN MULTICENTER STUDY [J].
LEGALL, JR ;
LEMESHOW, S ;
SAULNIER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24) :2957-2963
[10]   CIRCULATING INTERLEUKIN-8 CONCENTRATIONS IN PATIENTS WITH MULTIPLE ORGAN FAILURE OF SEPTIC AND NONSEPTIC ORIGIN [J].
MARTY, C ;
MISSET, B ;
TAMION, F ;
FITTING, C ;
CARLET, J ;
CAVAILLON, JM .
CRITICAL CARE MEDICINE, 1994, 22 (04) :673-679